Abstract
The 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) has become a standard procedure for the diagnosis, staging, and restaging in lymphoma patients. However, a relative high rate of false-positive results has been reported. We report a case of a 40-year-old man with a previous history of a nodal follicular lymphoma, stage IVA, treated with R-CHOP, which showed strong 18F-FDG uptake in the Waldeyer’s tonsillar ring during his follow-up, being considered highly suspicious of relapsed lymphoma. A surgical removal of the palatine tonsils and adenoids was performed, which showed reactive follicular hyperplasia. Furthermore, bone marrow biopsy revealed absence of neoplasia. The patient is still in follow-up with no signs of recurrent lymphoma. This case illustrates that, despite the high sensitivity for the detection of recurrent lymphoma, 18F-FDG uptake should be interpreted with great caution and confirmatory studies should be performed before any therapy.
References
Jerusalem G, Beguin Y, Fassotte MF, et al. Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin’s disease and non-Hodgkin’s lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging. Blood. 1999;94:429–33.
Beker DB, Berrak SG, Canpolat C, et al. False positivity of FDG-PET/CT in a child with Hodgkin disease. Pediatr Blood Cancer. 2008;50:881–3.
Long NM, Smith CS. Causes and imaging features of false positives and false negatives on F-PET/CT in oncologic imaging. Insights Imaging. 2011;2:679–98.
Nakamoto Y, Tatsumi M, Hammoud D, et al. Normal FDG distribution patterns in the head and neck: PET/CT evaluation. Radiology. 2005;234:879–85.
Rosenbaum SJ, Lind T, Antoch G, et al. False-positive FDG PET uptake–the role of PET/CT. Eur Radiol. 2006;16:1054–65.
Bhargava P, Parker JA, Dezube BJ. Pitfalls of diagnosis based on abnormal flow cytometry and [(18)F] fluorodeoxyglucose positron emission tomography. Clin Lymphoma Myeloma. 2008;8:117–20.
Crocchiolo R, Fallanca F, Giovacchini G, et al. Role of 18FDG-PET/CT in detecting relapse during follow-up of patients with Hodgkin’s lymphoma. Ann Hematol. 2009;88:1229–36.
Hosokai R, Imai C, Takachi T, et al. Reactive tonsillar enlargement with strong 18F-FDG uptake after chemotherapy for tonsillar diffuse large B-cell lymphoma. J Pediatr Hematol Oncol. 2011;33:e87–8.
Ioachim HL, Medeiros LJ. Reactive Lymphoid Hyperplasia. In: Ioachim HL, Medeiros LJ, editors. Lymph Node Pathology. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2009. p. 172–80.
Hasserjian RP, Chen S, Perkins SL, et al. Immunomodulator agent-related lymphoproliferative disorders. Mod Pathol. 2009;22:1532–40.
Tokuc G, Oktem S, Genc A. Nasopharyngeal lymphoid hyperplasia after therapy for childhood lymphomas. Acta Oncol. 2006;45:618–20.
Kojima M, Murayama K, Higuchi K, et al. Reactive lymphoid hyperplasia with giant follicles associated with post-therapeutic state of hematological malignancies: a report of six cases. Leuk Lymphoma. 2006;47:1404–6.
Chen YK, Su CT, Chi KH, et al. Utility of 18F-FDG PET/CT uptake patterns in Waldeyer’s ring for differentiating benign from malignant lesions in lateral pharyngeal recess of nasopharynx. J Nucl Med. 2007;48:8–14.
Metser U, Even-Sapir E. Increased (18) F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT. Semin Nucl Med. 2007;37:206–22.
Makis W, Ciarallo A, Lisbona R. Plasmablastic lymphoma of the oral cavity in an HIV-positive patient: staging with 18F-FDG PET/CT. Acta Radiol. 2011;52:970–2.
Kalkanis D, Kalkani M, Gomes H, et al. Interesting image. FDG-PET/CT in primary large B-cell lymphoma of the hard palate. Clin Nucl Med. 2010;35:24–5.
Kyo C, Kawaoka Y, Kinoshita K, et al. Mantle cell lymphoma presenting with a tumor of the hard palate. Intern Med. 2010;49:1663–6.
Blodgett TM, Fukui MB, Snyderman CH, et al. Combined PET-CT in the head and neck: part 1. Physiologic, altered physiologic and artifactual FDG uptake. Radiographics. 2005;25:897–912.
Wong WL, Gibson D, Sanghera B, et al. Evaluation of normal FDG uptake in palatine tonsil and its potential value for detecting occult head and neck cancers: a PET CT study. Nucl Med Commun. 2007;28:675–80.
Chung JH, Cho KJ, Lee SS, et al. Overexpression of Glut1 in lymphoid follicles correlates with false-positive (18) F-FDG PET results in lung cancer staging. J Nucl Med. 2004;45:999–1003.
Nakagawa T, Yamada M, Suzuki Y. 18F-FDG uptake in reactive neck lymph nodes of oral cancer: relationship to lymphoid follicles. J Nucl Med. 2008;49:1053–9.
Oguz A, Karadeniz C, Citak EC, et al. Thymic and adenotonsillar enlargement after successful treatment of malignancies. Pediatr Hematol Oncol. 2005;22:423–35.
Wöhrer S, Jaeger U, Kletter K, et al. 18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) visualizes follicular lymphoma irrespective of grading. Ann Oncol. 2006;17:780–4.
Good DJ, Gascoyne RD. Atypical lymphoid hyperplasia mimicking lymphoma. Hematol Oncol Clin North Am. 2009;23:729–45.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Feio, P.d.S.Q., Gomes, C.B.F., Nogueira, A.S. et al. Reactive Tonsillar Enlargement Showing Strong 18F-Fdg Uptake During the Follow-Up of Follicular Lymphoma. Head and Neck Pathol 7, 258–262 (2013). https://doi.org/10.1007/s12105-012-0400-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12105-012-0400-5